Financials
Income statement
Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 241.5K | 301.2K | 277.2K | 226.1K |
Selling general and admin | 51.3K | 51.1K | 92.6K | 145.2K |
Other operating expenses | — | — | — | — |
Operating income | -292.8K | -352.2K | -369.8K | -371.3K |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | -292.8K | -352.2K | -369.8K | -371.3K |
Tax provision | — | 0 | 0 | 0 |
Net income | -292.8K | -352.2K | -369.8K | -371.3K |
Basic EPS | — | 0 | 0.0 | 0.0 |
Diluted EPS | — | 0 | 0.0 | 0.0 |
Basic average shares | — | 131.4M | 131.4M | 131.4M |
Diluted average shares | — | 131.4M | 131.4M | 131.4M |
EBITDA | -292.8K | -352.2K | -369.8K | -371.3K |
Net income from continuing op. | -292.8K | -352.2K | -369.8K | -371.3K |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |